Abstract
Get full access to this article
View all access options for this article.
References
1.World Health Organization . WHO Coronavirus Disease (COVID-19) Dashboard . Accessed May 1, 2021 . https://covid19.who.int
2.
Anderson
RM
Vegvari
C
Truscott
J
Collyer
BS
. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination . Lancet . 2020 ;396 :1614 -1616 .
3.
Minglu
Z
. Some in US hesitant about taking it . China Daily Global . Accessed May 1, 2021 . https://global.chinadaily.com.cn/a/202012/11/WS5fd279d7a31024ad0ba9b1b6.html
4.
Fisher
KA
Bloomstone
SJ
Walder
J
, et al . Attitudes toward a potential SARS-CoV-2 vaccine: a survey of US adults . Ann Intern Med . 2020 ;173 :964 -973 .
5.China Central Radio and Television Station . 74.956 million doses of COVID-19 vaccine were given to key population in China [in Chinese] . Accessed May 1, 2021 . http://news.cctv.com/2021/03/21/ARTI44EuIHLCjkL50lphdNBw210321.shtml
6.
Moodley
K
Rossouw
T
. What could fair allocation of an efficacious COVID-19 vaccine look like in South Africa? Lancet Glob Health . 2021 ;9 :e106-e107. doi:10.1016/S2214-109X(20)30474-5
7.
MacDonald
NE
; SAGE Working Group on Vaccine Hesitancy . Vaccine hesitancy: definition, scope and determinants . Vaccine , 2015 ;33 :4161 -4164 .
8.
The Lancet
. COVID-19 vaccines: no time for complacency . Lancet . 2020 ;396 :1607 .
9.
Donovan
J
. Vaccines stop diseases safely—why all the suspicion? Nature . 2020 ;583 :680 -681 .
10.
Knipe
DM
Levy
O
Fitzgerald
KA
Mühlberger
E
. Ensuring vaccine safety . Science . 2020 ;370 :1274 -1275 .